OMERS Administration Corp’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,400
Closed -$77.2K 1086
2024
Q1
$77.2K Buy
+35,400
New +$77.2K ﹤0.01% 348